Dermata Therapeutics (DRMA) Common Equity (2020 - 2026)
Dermata Therapeutics (DRMA) recorded Common Equity of $6.41 million in Q1 2026, down 12.2% from $7.3 million a year earlier but up 3.0% from the prior quarter.
Powered by 
Analysis
Dermata Therapeutics (DRMA) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Dermata Therapeutics reported Common Equity of $6.22 million, up 298.7% from FY2024.
- Across earlier years, Common Equity came in at $1.56 million in FY2024 (-75.4%), $6.36 million in FY2023 (+5.5%), $6.02 million in FY2022 (-40.4%) and $10.11 million in FY2021.
- Quarterly Common Equity has ranged from -$505,802 in Q2 2021 to $12.49 million in Q3 2021 over the past five years.
- On a year-over-year basis, Common Equity rose in three of the last eight quarters, with growth averaging 33.9%.
- Peak year-over-year performance for Common Equity in the last five years was growth of 298.7% in Q4 2025, against a decline of 75.4% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $6.22 million (Q4 2025), $3.96 million (Q3 2025) and $5.61 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Procter & Gamble | 346.43 Bn | 302.42 Bn | 10.28 Bn | 54.31 Bn |
| 2 | Colgate Palmolive | 69.04 Bn | 64.10 Bn | 3.30 Bn | 566.00 Mn |
| 3 | Estee Lauder Companies | 34.63 Bn | 22.70 Bn | 2.74 Bn | 3.81 Bn |
| 4 | Kenvue | 34.35 Bn | 29.97 Bn | 2.30 Bn | 10.55 Bn |
| 5 | Kimberly Clark | 32.85 Bn | 30.17 Bn | 1.60 Bn | 1.87 Bn |
| 6 | Church & Dwight | 22.69 Bn | 21.21 Bn | 693.90 Mn | 4.35 Bn |
| 7 | Clorox | 9.84 Bn | 8.28 Bn | 804.00 Mn | 252.00 Mn |
| 8 | e.l.f. Beauty | 6.00 Bn | 4.97 Bn | 398.84 Mn | 1.17 Bn |
| 9 | Reynolds Consumer Products | 4.65 Bn | 4.32 Bn | 245.00 Mn | 2.31 Bn |
| 10 | Dermata Therapeutics | 4.59 Mn | 4.59 Mn | - | 6.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 6.41 Mn |
| Dec 31, 2025 | 6.22 Mn |
| Sep 30, 2025 | 3.96 Mn |
| Jun 30, 2025 | 5.61 Mn |
| Mar 31, 2025 | 7.30 Mn |
| Dec 31, 2024 | 1.56 Mn |
| Sep 30, 2024 | 4.74 Mn |
| Jun 30, 2024 | 3.32 Mn |
| Mar 31, 2024 | 3.81 Mn |
| Dec 31, 2023 | 6.36 Mn |
| Sep 30, 2023 | 6.41 Mn |
| Jun 30, 2023 | 8.03 Mn |
| Mar 31, 2023 | 8.09 Mn |
| Dec 31, 2022 | 6.02 Mn |
| Sep 30, 2022 | 7.47 Mn |
| Jun 30, 2022 | 9.66 Mn |
| Mar 31, 2022 | 7.85 Mn |
| Dec 31, 2021 | 10.11 Mn |
| Sep 30, 2021 | 12.49 Mn |
| Jun 30, 2021 | -505,802.00 |
API Access
Dermata Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=DRMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "DRMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=DRMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();